Achieve Life Sciences, Inc. (ACHV) vs Avalo Therapeutics, Inc. (AVTX)
A side-by-side comparison of Achieve Life Sciences, Inc. and Avalo Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACHV
Achieve Life Sciences, Inc.
$7.01HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
AVTX
Avalo Therapeutics, Inc.
$14.60HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACHV vs AVTX
growth of $100 · dividends reinvested · last 10yACHV -99.3% (-38.9%/yr)AVTX -99.9% (-48.7%/yr)ACHV compounded faster over this window
Log scale — wide-divergence pair
ACHV AVTX
ACHV vs AVTX: by the numbers
- •AVTX is the larger company ($767M vs $720M market cap).
- •Both run net losses; ACHV's is the smaller (0.00% vs -170055.93% net margin).
Metrics side by side
Valuation
| Metric | ACHV | AVTX |
|---|---|---|
| P/S ratio | N/A | 13007.76 |
| P/B ratio | N/A | 1.71 |
Profitability
| Metric | ACHV | AVTX |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -123601.69% |
| Net margin | 0.00% | -170055.93% |
| ROE | N/A | -22.36% |
| ROIC | N/A | -19.45% |
Growth (annualized)
| Metric | ACHV | AVTX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -60.88% |
| Total return CAGR (5Y) | -4.33% | -70.04% |
Frequently asked
- How have ACHV and AVTX total returns compared?
- Over the past 10 years, ACHV delivered -39.18% and AVTX delivered -48.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.